High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease
- PMID: 2368170
- DOI: 10.1177/030089169007600309
High prevalence of occult papillary thyroid carcinoma in a surgical series for benign thyroid disease
Abstract
In a surgical series of 277 consecutive patients operated on the thyroid for benign diseases, a high prevalence rate (10.5%) of occult papillary carcinoma was found by means of an accurate histologic examination. Indications for surgery were euthyroid multinodular goiter in 25 patients, autonomously hyperfunctioning adenoma in 2 and Graves' disease in 2 patients. Neoplastic foci were unilaterally found in 25 cases but multifocally in 6 and bilaterally in 4 cases: the diameters ranged from 2-10 mm. After operation (14 subtotal and 15 total thyroidectomies), all patients received TSH-suppressive doses of T4. At a mean follow-up of 5.6 years, neither local recurrences nor lymph node or distant metastases had occurred; no patient died of the tumor. In keeping with other surgical and autopsy series, the prevalence of occult thyroid carcinoma in a normal population is calculated to be about 5-10%, whereas it is known that the prevalence of clinically evident thyroid cancer is only 0.05%. This means that only 1-2% of occult carcinomas may evolve in an overt tumor during life. In view of such an epidemiologic difference and the favorable course of our patients, although the mean follow-up is rather short, we suggest that lobectomy plus T4 treatment may be considered an adequate therapeutic approach in patients with occult papillary thyroid carcinoma.
Similar articles
-
Occult thyroid carcinoma in our experience -- should we reconsider total thyroidectomy for benign thyroid pathology?Chirurgia (Bucur). 2014 Mar-Apr;109(2):191-7. Chirurgia (Bucur). 2014. PMID: 24742409
-
Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up.Minerva Endocrinol. 2013 Sep;38(3):269-79. Minerva Endocrinol. 2013. PMID: 24126547
-
Incidental thyroid carcinoma in patients with Graves' disease.Am J Surg. 2008 Mar;195(3):292-7; discussion 297. doi: 10.1016/j.amjsurg.2007.12.006. Am J Surg. 2008. PMID: 18206132
-
Thyroid cancer yield in patients with Graves' disease.Minerva Endocrinol. 2003 Sep;28(3):205-12. Minerva Endocrinol. 2003. PMID: 14605602 Review.
-
[Surgical treatment of multinodular goiter at the Instituto Nacional de la Nutrición Salvador Zubirán].Rev Invest Clin. 1997 Mar-Apr;49(2):105-9. Rev Invest Clin. 1997. PMID: 9380962 Review. Spanish.
Cited by
-
Papillary microcarcinomas of the thyroid gland and immunohistochemical analysis of expression of p53 protein in papillary microcarcinomas.J Transl Med. 2006 Jul 5;4:28. doi: 10.1186/1479-5876-4-28. J Transl Med. 2006. PMID: 16822319 Free PMC article.
-
Clinical efficacy of fine-needle aspiration biopsy of thyroid nodules in males.J Surg Res. 2010 Apr;159(2):645-50. doi: 10.1016/j.jss.2009.08.013. Epub 2009 Sep 4. J Surg Res. 2010. PMID: 19932905 Free PMC article.
-
Managing thyroid microcarcinomas.Yonsei Med J. 2012 Jan;53(1):1-14. doi: 10.3349/ymj.2012.53.1.1. Yonsei Med J. 2012. PMID: 22187228 Free PMC article. Review.
-
Total versus hemithyroidectomy for microscopic papillary thyroid cancer.J Endocrinol Invest. 2012 May;35(5):464-8. doi: 10.3275/7963. Epub 2011 Sep 27. J Endocrinol Invest. 2012. PMID: 21952495
-
Active surveillance for patients with very low-risk thyroid cancer.Laryngoscope Investig Otolaryngol. 2020 Feb 7;5(1):175-182. doi: 10.1002/lio2.356. eCollection 2020 Feb. Laryngoscope Investig Otolaryngol. 2020. PMID: 32128446 Free PMC article. Review.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical